Log In
Print this Print this

Jalyn, dutasteride/tamsulosin (Duodart)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCombination of dutasteride, a 5-alpha reductase inhibitor, and tamsulosin, an adrenergic receptor alpha 1 antagonist
Molecular Target 5-alpha reductase ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of Action5-alpha reductase inhibitor; Adrenergic receptor alpha 1 (ADRA1) antagonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentApproved
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today